Unknown

Dataset Information

0

Interferon-tau attenuates uptake of nanoparticles and secretion of interleukin-1? in macrophages.


ABSTRACT:

Background

Type I interferons (IFNs), including IFN-alpha (IFNA) and IFN-beta (IFNB), have anti-inflammatory properties and are used to treat patients with autoimmune and inflammatory disorders. However, little is known of the role of IFN-tau (IFNT), a type I IFN produced by ruminant animals for inflammation. Because IFNB has recently been shown to inhibit nucleotide-binding oligomerization domain-like receptor, pyrin domain-containing 3 (NLRP3) inflammasome activation and subsequent secretion of the potent inflammatory cytokine interleukin (IL)-1?, we examined the effects of ruminant IFNT on NLRP3 inflammasome-mediated IL-1? secretion in human THP-1 macrophages.

Methods and results

IFNT dose-dependently inhibited IL-1? secretion induced by nano-silica, a well-known activators of NLRP3 inflammasomes, in human macrophages primed with lipopolysaccharide (LPS, TLR4 agonist) and Pam3CSK4 (TLR1/2 agonist). IFNT also suppressed phagocytosis of nano-silica and reactive oxygen species (ROS) generation. Western blot analysis showed that IFNT inhibited both pro-IL-1? and mature IL-1?. In addition, real-time RT-PCR analysis showed that IFNT suppressed IL-1? mRNA expression induced by LPS and Pam3CSK4. Although nano-silica particles did not induce IL-10 secretion, IFNT induced IL-10 secretion in a dose-dependent manner. Furthermore, IFNT-suppressed IL-1? secretion was restored by anti-IL-10 neutralizing antibody.

Conclusions

Ruminant IFNT inhibits NLRP3 inflammasome-driven IL-1? secretion in human macrophages via multiple pathways, including the uptake of nano-silica particles, generation of ROS, and IL-10-mediated inhibition of pro-IL-1? induction. It may be a therapeutic alternative to IFNA and IFNB.

SUBMITTER: Hara K 

PROVIDER: S-EPMC4259327 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Interferon-tau attenuates uptake of nanoparticles and secretion of interleukin-1β in macrophages.

Hara Kyoko K   Shirasuna Koumei K   Usui Fumitake F   Karasawa Tadayoshi T   Mizushina Yoshiko Y   Kimura Hiroaki H   Kawashima Akira A   Ohkuchi Akihide A   Matsuyama Shuichi S   Kimura Koji K   Takahashi Masafumi M  

PloS one 20141208 12


<h4>Background</h4>Type I interferons (IFNs), including IFN-alpha (IFNA) and IFN-beta (IFNB), have anti-inflammatory properties and are used to treat patients with autoimmune and inflammatory disorders. However, little is known of the role of IFN-tau (IFNT), a type I IFN produced by ruminant animals for inflammation. Because IFNB has recently been shown to inhibit nucleotide-binding oligomerization domain-like receptor, pyrin domain-containing 3 (NLRP3) inflammasome activation and subsequent sec  ...[more]

Similar Datasets

| S-EPMC8557205 | biostudies-literature
| S-EPMC5825906 | biostudies-literature
| S-EPMC7851739 | biostudies-literature
2024-09-01 | GSE271595 | GEO
2022-02-17 | PXD029017 | Pride
| S-EPMC5874908 | biostudies-literature
| S-EPMC7940371 | biostudies-literature
| S-EPMC4591798 | biostudies-literature
| S-EPMC7565447 | biostudies-literature
| S-EPMC4670995 | biostudies-literature